77 related articles for article (PubMed ID: 2316546)
1. Liquefaction times of fatty-type suppositories with and without progesterone.
Fulper LD; Cleary RW; Harland EC; Hikal AH; Jones AB
Am J Hosp Pharm; 1990 Mar; 47(3):602-3. PubMed ID: 2316546
[No Abstract] [Full Text] [Related]
2. Preparation of progesterone suppositories.
Roffe BD; Zimmer RA; Derewicz HJ
Am J Hosp Pharm; 1977 Dec; 34(12):1344-6. PubMed ID: 596385
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro study of antimalarial rectal suppositories.
Regdon G; Schirm I; Regdon G
Pharmazie; 1995 Jun; 50(6):439-40. PubMed ID: 7651986
[No Abstract] [Full Text] [Related]
4. [Influence of excipients and storage conditions on drug preservation. IV. Suppositories with acetyl salicylic acid base].
Delonca H; Puech A; Segura G; Joachim J
J Pharm Belg; 1972; 27(1):50-6. PubMed ID: 5017455
[No Abstract] [Full Text] [Related]
5. [Effects of fat excipients and antioxidants on conservation of suppositories containing phenothiazine derivatives (author's transl)].
Bossert J; Mathis C
J Pharm Belg; 1976; 31(4):381-96. PubMed ID: 978385
[No Abstract] [Full Text] [Related]
6. Softening and liquefaction temperature of suppositories.
SETNIKAR I; FANTELLI S
J Pharm Sci; 1963 Jan; 52():38-43. PubMed ID: 13988205
[No Abstract] [Full Text] [Related]
7. [Characterization of storage-induced release reductions in suppositories (author's transl)].
Voigt R; Grohmann A; Bornschein M
Pharmazie; 1981 Sep; 36(9):631-3. PubMed ID: 7301905
[TBL] [Abstract][Full Text] [Related]
8. Plasma progesterone levels after using high dose suppositories. A preliminary report.
van der Meer YG; van Loenen AC; Loendersloot EW; Jaszmann LJ
Pharm Weekbl Sci; 1982 Oct; 4(5):135-6. PubMed ID: 7145597
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
10. [Liberation of water soluble active principles from suppositories. Influence of rheologic properties of utilized fat excipients].
Moës A
J Pharm Belg; 1974; 29(1):85-6. PubMed ID: 4831721
[No Abstract] [Full Text] [Related]
11. Evaluation of aminophylline suppositories prepared in a hospital pharmacy.
Fujii T; Kubota A; Togawa K; Mizushima N
Tokai J Exp Clin Med; 1982 May; 7(3):371-83. PubMed ID: 7123575
[TBL] [Abstract][Full Text] [Related]
12. [Glycerine esters of various higher fatty acids as pharmaceutic aids. VII. Thermal expansion].
Lichnerová I; Chalabala M
Cesk Farm; 1974 Jul; 23(6):219-21. PubMed ID: 4418318
[No Abstract] [Full Text] [Related]
13. [On the effect of storage on the release of trapidil from suppositories (author's transl)].
Bornschein M; Grohmann A; Voigt R
Pharmazie; 1980 Jan; 35(1):40-2. PubMed ID: 7384175
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the physical properties of lipid excipients for suppositories during storage].
Moës AJ
Pharm Acta Helv; 1980; 55(11-12):307-11. PubMed ID: 7208532
[No Abstract] [Full Text] [Related]
15. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
Regdon G; Deák D; Regdon G; Muskó Z; Erös I
Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone.
Nillius SJ; Johansson ED
Am J Obstet Gynecol; 1971 Jun; 110(4):470-7. PubMed ID: 5582003
[No Abstract] [Full Text] [Related]
17. Plasma progesterone levels after intramuscular or rectal administration of progesterone.
Nillius SJ; Johansson ED
Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:46. PubMed ID: 5287114
[No Abstract] [Full Text] [Related]
18. Efficacy of oral micronized progesterone in the treatment of luteal phase defects.
Frishman GN; Klock SC; Luciano AA; Nulsen JC
J Reprod Med; 1995 Jul; 40(7):521-4. PubMed ID: 7473442
[TBL] [Abstract][Full Text] [Related]
19. [Vaginal estradiol and progesterone in climacteric therapy].
Pedersen OD; Jensen HK
Ugeskr Laeger; 1989 Aug; 151(32):2016-9. PubMed ID: 2672496
[TBL] [Abstract][Full Text] [Related]
20. [Rheologic properties of excipient fats for suppositories].
Moës A
J Pharm Belg; 1974 Mar; 29(2):113-25. PubMed ID: 4840383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
